Solid Dosage
Diabetes
GEA designs, produces and delivers innovative, integrated solutions for every stage of the manufacturing process of anti-diabetic drugs
Manufacturing Anti-Diabetics to Meet the Needs of the Growing Diabetes Market
With diabetes and the global anti-diabetes drug market on the rise, demand for GEA technologies for the production of these life-saving drugs is already high and set to increase, particularly in new markets and emerging economies
It is estimated that approximately 6.4% of the adult population worldwide has diabetes, leading to a huge demand for oral anti-diabetes drugs. To be able to cater for this demand, high-volume or mass production of these medicines is a fundamental requirement. It enables companies to produce goods faster and reduce the overall per unit production cost, allowing them to make anti-diabetes medications available to less-developed countries.
GEA has been instrumental in designing, producing and delivering innovative, integrated solutions for every stage of the manufacturing process: from materials handling to tablet coating, automation and monitoring. We continue to support this high-volume batch-based production with ongoing improvements and innovative developments.
One example is our range of double-sided tablet presses to accommodate the fact that many oral anti-diabetes medicines are bilayer combination drugs, consisting of two separate layers for each API.
Another trend that we have observed is the move towards continuous manufacturing (CM). Providing increased yields, lower utility consumption and reduced waste, CM meets the industry’s demands for improved production economics and increased manufacturing flexibility.
Focusing on quality during the whole product lifecycle and decreasing any associated risks, GEA is helping its customers to develop, evaluate and optimize continuous processing techniques to enable them to bring new products to market faster and cheaper.
Produkte und Technologien
Zeigt 4 von 28 an
Analyse-, Inline Steuer- und Messvorrichtungen
Durch die Verbindung von Prozessüberwachung per Online-Analysetools mit soliden Verfahrenstechnikprinzipien und fortschrittlichen Prozessmodellierungsmethoden können Prozesse aktiv überwacht werden, um Eingabevariationen zu kompensieren.
CIP/SIP-Lösungen
Innovative CIP-Konzepte von GEA erfüllen umfassende hohe Normen. Unsere Experten garantieren die Produktsicherheit an jeder Stelle des Prozesses. Jede Aktualisierung wird an die individuellen lokalen Bedingungen und Anforderungen der Kunden angepasst und führt zu erheblichen Einsparungen.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Containment Valves
Competitively priced with short delivery times, BUCK® valves are fully GMP compliant, offer robust, free-oriented docking, a dust- and contamination-free interface, and quick and easy maintenance. And, with thousands of global implementations and 20 years of experience.
Downloads
GEA Insights
Gesellschaftliches Engagement: Gemeinsam Gutes bewirken
Zur Unterstützung des gesellschaftlichen Engagements bietet GEA seinen Mitarbeitern einen Tag bezahlten Urlaub pro Jahr.
How a digital rotary parlor supports sustainable dairy farming
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
Zukunft gestalten: GEA-CEO Stefan Klebert zur Mission 30
Nachdem GEA die Ziele der Mission 26 zwei Jahre früher erreicht hat, setzt sich das Unternehmen ambitionierte Ziele, um in den kommenden Jahren profitabel zu wachsen.
